Biscayne NeuroTherapeutics

About:

Biscayne Neurotherapeutics is a clinical-stage biotechnology company which develops novel drugs for central nervous system disorders.

Website: http://biscayneneuro.com/

Top Investors: Quark Venture, Mesa Verde Venture Partners

Description:

Biscayne Neurotherapeutics is a clinical-stage biotechnology company developing novel therapies for difficult-to-treat neurological disorders. Biscayne’s lead compound, BIS-001, is in clinical development for the treatment of refractory forms of epilepsy. Biscayne Neurotherapeutics has an experienced executive team with an extensive track record of successful drug development, and its scientific advisors include a number of highly respected experts studying seizure and other CNS disorders. The company is headquartered in Miami, Florida, and benefits from the growing entrepreneurial South Florida biomedical sector.